Search research articles
Contact Us
Filters
Showing results (31-40 of 36) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 36 results.
Journal of Medicinal Chemistry
|
May 23, 2017
Discovery of N-(5-Fluoropyridin-2-yl)-6-methyl-4-(pyrimidin-5-yloxy)picolinamide (VU0424238): A Novel Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Selected for Clinical Evaluation
Andrew S Felts, Alice L Rodriguez, Anna L Blobaum, et al.
ACS Chemical Neuroscience
|
April 22, 2018
Discovery and Optimization of Potent and CNS Penetrant M<sub>5</sub>-Preferring Positive Allosteric Modulators Derived from a Novel, Chiral N-(Indanyl)piperidine Amide Scaffold
Aaron M Bender, Hyekyung P Cho, Kellie D Nance, et al.
ACS Medicinal Chemistry Letters
|
February 16, 2017
Discovery of VU0467485/AZ13713945: An M<sub>4</sub> PAM Evaluated as a Preclinical Candidate for the Treatment of Schizophrenia
Michael R Wood, Meredith J Noetzel, Bruce J Melancon, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 23, 2019
VU6005806/AZN-00016130, an advanced M<sub>4</sub> positive allosteric modulator (PAM) profiled as a potential preclinical development candidate
Darren W Engers, Bruce J Melancon, Allison R Gregro, et al.
ACS Chemical Neuroscience
|
January 25, 2026
Discovery of VU6025733 (AG06827): A Highly Selective, Orally Bioavailable, and Structurally Distinct M<sub>4</sub> Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM) with Robust <i>In Vivo</i> Efficacy
Alison R Gregro, Charlotte Park, Madeline F Long, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 29, 2019
SAR inspired by aldehyde oxidase (AO) metabolism: Discovery of novel, CNS penetrant tricyclic M<sub>4</sub> PAMs
Trevor C Chopko, Changho Han, Alison R Gregro, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 36) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 36 results.
Journal of Medicinal Chemistry
|
May 23, 2017
Discovery of N-(5-Fluoropyridin-2-yl)-6-methyl-4-(pyrimidin-5-yloxy)picolinamide (VU0424238): A Novel Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Selected for Clinical Evaluation
Andrew S Felts, Alice L Rodriguez, Anna L Blobaum, et al.
ACS Chemical Neuroscience
|
April 22, 2018
Discovery and Optimization of Potent and CNS Penetrant M<sub>5</sub>-Preferring Positive Allosteric Modulators Derived from a Novel, Chiral N-(Indanyl)piperidine Amide Scaffold
Aaron M Bender, Hyekyung P Cho, Kellie D Nance, et al.
ACS Medicinal Chemistry Letters
|
February 16, 2017
Discovery of VU0467485/AZ13713945: An M<sub>4</sub> PAM Evaluated as a Preclinical Candidate for the Treatment of Schizophrenia
Michael R Wood, Meredith J Noetzel, Bruce J Melancon, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 23, 2019
VU6005806/AZN-00016130, an advanced M<sub>4</sub> positive allosteric modulator (PAM) profiled as a potential preclinical development candidate
Darren W Engers, Bruce J Melancon, Allison R Gregro, et al.
ACS Chemical Neuroscience
|
January 25, 2026
Discovery of VU6025733 (AG06827): A Highly Selective, Orally Bioavailable, and Structurally Distinct M<sub>4</sub> Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM) with Robust <i>In Vivo</i> Efficacy
Alison R Gregro, Charlotte Park, Madeline F Long, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 29, 2019
SAR inspired by aldehyde oxidase (AO) metabolism: Discovery of novel, CNS penetrant tricyclic M<sub>4</sub> PAMs
Trevor C Chopko, Changho Han, Alison R Gregro, et al.
Page
of 4